Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/2010
11/24/2010CN101889989A Amoxicillin enteric controlled-release preparation composite and preparation method thereof
11/24/2010CN101889988A Tiamulin fumarate effervescent granules for treating pneumonia and dysentery of livestock and poultry
11/24/2010CN101889987A Method for preparing novel cefixime tablets and cefixime capsules
11/24/2010CN101889984A Amoxicillin enteric-coated formulation composition and preparation method thereof
11/24/2010CN101889979A Itraconazole injection for dogs and preparation method thereof
11/24/2010CN101889976A Acyclovir injection and preparation method thereof
11/24/2010CN101889973A Itraconazole gel for dogs and preparation method thereof
11/24/2010CN101889953A Device and method for manufacturing drug smoke liquid and drug smoke
11/24/2010CN101889736A Chinese medicinal health-care sock and production method thereof
11/24/2010CN101889593A Functional incense and preparation method and application thereof
11/24/2010CN101380302B Potasium dehydroandrographolide succinate injection and production method thereof
11/24/2010CN101314579B Waterless Peramivir crystal and medicament composition thereof
11/24/2010CN101235019B 3,5-diiodo salicylaldehyde-4-(omega-aminoalkyl)morpholine metal complexes, preparation method and use thereof
11/24/2010CN101234116B Powder needle injection containing caderofloxacin lactate
11/24/2010CN101234115B Water needle injection containing caderofloxacin lactate
11/24/2010CN101230043B 3-oxide-2-methylamide derivatives as well as preparation method and use thereof
11/24/2010CN101210020B Cephalosporin compound
11/24/2010CN101205539B Highly pathogenic PRRS virus recombinant plasmid and genetic engineering vaccines
11/24/2010CN101195627B New application of benzo [C] phenanthridine and protopine in producing overriding resistant bacterium medicament
11/24/2010CN101181305B Extract of acaleph toxin as well as preparation method and usage thereof
11/24/2010CN101152570B Epitope vaccine of hog cholera virus and its preparing process
11/24/2010CN101152189B Polyene phosphatidyl choline injection and method for preparing the same
11/24/2010CN101120947B Beta-l-2'-deoxy-nucleosides for the treatment of hepatitis b
11/24/2010CN101045715B Heterocycle inhibitor for glycogen synthase kinase gsk-3
11/24/2010CN100998595B Medicine composition containing cefateram cyclodextrin capsule and its preparing method
11/23/2010US7838644 oversulfation of epiK-N sulfate to obtain an epiK5-amine-O-oversulfate with very high sulfation degree which by subsequent N-sulfation provides new epiK5-N,O-oversulfate-derivatives; free of activity on the coagulation parameters and useful in the cosmetic or pharmaceutical field
11/23/2010US7838637 Single-chain multiple antigen-binding molecule, its preparation and use
11/23/2010US7838555 Useful in the treatment and prophylaxis of inflammatory conditions or in the amelioration of symptoms resulting from or facilitated by an inflammatory condition in a mammalian animal including human and primate, non-mammalian animal and
11/23/2010US7838541 Methods of using aryl ureas to treat diseases mediated by the VEGF induced signal transduction pathway characterized by abnormal angiogenesis or hyperpermeability processes.
11/23/2010US7838537 Viral polymerase inhibitors
11/23/2010US7838289 Assay utilizing multipotent adult stem cells
11/23/2010US7838275 Anti-HIV and anti-tumor peptides and fragments of lysozyme
11/23/2010US7838001 Synthetic peptides useful in biological essays for detecting infections caused by group O HIV-1 viruses
11/23/2010CA2516642C Methods for treatment of hiv or malaria using combinations of chloroquine and protease inhibitors
11/23/2010CA2503223C Meso-substituted porphyrins
11/23/2010CA2459380C Reverse hydroxamic acid derivatives
11/23/2010CA2438870C Novel inhibitors of formation of advanced glycation endproducts (ages)
11/23/2010CA2354148C Aerosol formulations for buccal and pulmonary application
11/23/2010CA2302010C 9a-azalides as veterinary antimicrobial agents
11/23/2010CA2252565C Dna vaccine formulations
11/23/2010CA2223989C Prodrugs of pharmaceuticals with improved bioavailability
11/23/2010CA2132421C Broadly reactive opsonic antibodies that react with common staphylococcal antigens
11/18/2010WO2010132864A1 Methods of treating hiv patients with anti-fibrotics
11/18/2010WO2010132852A2 Protease inhibitors
11/18/2010WO2010132839A2 Aminoglycoside dosing regimens
11/18/2010WO2010132777A2 Treatment of urinary tract infections with antibacterial aminoglycoside compounds
11/18/2010WO2010132770A1 Treatment of klebsiella pneumoniae infections with antibacterial aminoglycoside compounds
11/18/2010WO2010132768A1 Antibacterial derivatives of sisomicin
11/18/2010WO2010132760A1 Antibacterial derivatives of tobramycin
11/18/2010WO2010132759A1 Antibacterial derivatives of dibekacin
11/18/2010WO2010132758A2 Ospc-based diagnostic test for lyme disease
11/18/2010WO2010132663A1 Pegylated azapeptide derivatives as hiv protease inhibitors
11/18/2010WO2010132601A1 Antiviral compounds
11/18/2010WO2010132538A1 Fused tricyclic aryl compounds useful for the treatment of viral diseases
11/18/2010WO2010131865A2 Antimicrobial composition with an activity against an antibiotic-resistant strain
11/18/2010WO2010131695A1 Modified double-stranded rna
11/18/2010WO2010131691A1 Polyketide compound
11/18/2010WO2010131118A2 Polymorphs of etravirine and processes for preparation thereof
11/18/2010WO2010130897A1 Method for detoxification of lipopolysaccharide (lps) or of lipid a of gram-negative bacteria
11/18/2010WO2010130896A2 Method for admixing the lipopolysaccharide (lps) of gram-negative bacteria
11/18/2010WO2010130842A1 Thieno [2, 3-b] pyridine derivatives as viral replication inhibitors
11/18/2010WO2010130708A1 Beta-lactamase inhibitors
11/18/2010WO2010130663A1 Bifidobacterium longum ncc2705 (cncm i-2618) and immune disorders
11/18/2010WO2010130662A1 LACTOBACILLUS JOHNSONII La1 NCC533 (CNCM I-1225) AND IMMUNE DISORDERS
11/18/2010WO2010130468A1 New medicines for topic use based on sulfated hyaluronic acid as activating or inhibiting agent of the cytokine activity
11/18/2010WO2010130466A1 Sulphated hyaluronic acids as regulator agents of the cytokine activity
11/18/2010WO2010130392A1 Desfesoterodine in the form of a tartaric acid salt
11/18/2010WO2010130224A1 Thiophene derivatives
11/18/2010WO2010130034A1 Inhibitors of human immunodeficiency virus replication
11/18/2010WO2010130028A1 Compositions suitable for the topical treatment of fungal infections of the skin and nails
11/18/2010WO2010130007A1 Antimicrobial compounds
11/18/2010WO2010110931A3 Glycoconjugate vaccines
11/18/2010WO2010102171A3 Secreted ap2 and methods of inhibiting same
11/18/2010WO2010034670A3 Host cell kinases as targets for antiviral therapies against hcv infection
11/18/2010WO2007133816A3 Methods of treating pain and inflammation in neuronal tissue using il-31ra and osmrb antagonists
11/18/2010US20100292791 Fully synthetic implantable multi-phased scaffold
11/18/2010US20100292456 Rna interference mediating small rna molecules
11/18/2010US20100292345 Therapeutic uses of cannabigerol
11/18/2010US20100292333 Compositions suitable for the topical treatment of fungal infections of the skin and nails
11/18/2010US20100292329 4-hydroxy benzoate derivatives for use in the treatment of infection, inflammation or pain
11/18/2010US20100292324 Multi-Substituted Diarylanilines as Non-Nucleoside HIV Reverse Transcriptase Inhibitors, and Preparation and Use Thereof
11/18/2010US20100292318 Antibacterial composition comprising salvia extracts
11/18/2010US20100292317 Antimicrobial and radioprotective compounds
11/18/2010US20100292274 Haloalkyl heteroaryl benzamide compounds
11/18/2010US20100292262 4 (pyrrolo[2,3-c]pyridine-3-yl)pyrimidin-2-amine derivatives
11/18/2010US20100292261 Quorum sensing antagonist, method of preventing a biofilm formation using the quorum sensing antagonist and method of reducing a bacterial contamination using the quorum sensing antagonist
11/18/2010US20100292260 6-vinyl pyrimidine and pyrimidinone derivatives and the use thereof
11/18/2010US20100292258 Substituted aromatic heterocyclic compounds as fungicides
11/18/2010US20100292246 Formulations of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1h-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione
11/18/2010US20100292234 Triazole fused heteroaryl compounds and methods of use thereof
11/18/2010US20100292233 Dihydro-1h-pyrrolo[1,2-a]indol-1-yl carboxylic acid derivatives which act as s1p1 agonists
11/18/2010US20100292232 Non-nucleoside reverse transcriptase inhibitors
11/18/2010US20100292231 Indazole Compounds for Treating Inflammatory Disorders, Demyelinating Disorders and Cancers
11/18/2010US20100292227 Inhibitors of human immunodeficiency virus replication
11/18/2010US20100292219 Tertiary amine substituted peptides useful as inhibitors of hcv replication
11/18/2010US20100292213 Anti-Inflammatory Agents
11/18/2010US20100292197 Compositions and Methods for Increasing Telomerase Activity
11/18/2010US20100292195 Low burst polymers and methods to produce polymer
11/18/2010US20100292193 Radioprotective drugs
11/18/2010US20100292189 Oligonucleotide analog and method for treating flavivirus infections
1 ... 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 ... 1798